High Falls Advisors’s AbbVie ABBV Stock Holding History

High Falls Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$280K	Sell	1,226 -425	-26%	-$96.8K	0.06%	111
2025 Q3	$382K	Buy	1,651 +2	+0.1%	+$407	0.08%	90
2025 Q2	$306K	Sell	1,649 -214	-11%	-$39.8K	0.07%	103
2025 Q1	$390K	Buy	1,863 +57	+3%	+$11.1K	0.09%	73
2024 Q4	$321K	Sell	1,806 -10	-0.6%	-$1.84K	0.07%	82
2024 Q3	$359K	Buy	1,816 +18	+1%	+$3.36K	0.08%	78
2024 Q2	$308K	Hold	1,798	–	–	0.07%	86
2024 Q1	$327K	Hold	1,798	–	–	0.08%	84
2023 Q4	$279K	Hold	1,798	–	–	0.07%	83
2023 Q3	$268K	Hold	1,798	–	–	0.08%	80
2023 Q2	$242K	Hold	1,798	–	–	0.07%	92
2023 Q1	$287K	Hold	1,798	–	–	0.09%	76
2022 Q4	$291K	Hold	1,798	–	–	0.09%	86
2022 Q3	$241K	Hold	1,798	–	–	0.08%	93
2022 Q2	$275K	Hold	1,798	–	–	0.09%	90
2022 Q1	$291K	Hold	1,798	–	–	0.08%	92
2021 Q4	$243K	Buy	+1,798	New	+$212K	0.06%	111
2019 Q2	–	Sell	-2,617	Closed	-$211K	–	98
2019 Q1	$211K	Sell	2,617 -160	-6%	-$13.1K	0.07%	87
2018 Q4	$256K	Sell	2,777 -250	-8%	-$22K	0.1%	62
2018 Q3	$286K	Sell	3,027 -1,401	-32%	-$133K	0.1%	67
2018 Q2	$410K	Buy	4,428 +186	+4%	+$18.2K	0.14%	60
2018 Q1	$402K	Sell	4,242 -147	-3%	-$16.1K	0.14%	56
2017 Q4	$424K	Sell	4,389 -5	-0.1%	-$471	0.15%	57
2017 Q3	$390K	Buy	4,394 +18	+0.4%	+$1.37K	0.15%	60
2017 Q2	$317K	Buy	4,376 +60	+1%	+$4.03K	0.12%	64
2017 Q1	$281K	Buy	+4,316	New	+$271K	0.12%	72

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

High Falls Advisors's ABBV Position: Q4 2025 in Review

High Falls Advisors reduced its AbbVie (ABBV) stake by 26% in Q4 2025, selling an estimated $96.8K and leaving 1,226 shares worth $280K. The position accounts for 0.06% of the portfolio, ranked #111.

High Falls Advisors first reported a position in ABBV in Q1 2017 and has held it in 26 quarters since. The position peaked at $424K in Q4 2017. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

High Falls Advisors held 1,226 shares of AbbVie worth $280K as of Q4 2025.
High Falls Advisors sold 425 AbbVie shares in Q4 2025, an estimated $96.8K.
AbbVie made up 0.06% of High Falls Advisors's portfolio in Q4 2025, its #111 holding.
High Falls Advisors first reported a position in AbbVie in Q1 2017 and has held it in 26 quarters since.
High Falls Advisors's AbbVie position peaked at $424K in Q4 2017.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on High Falls Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.